Though rare, blood clotting from vaccine likely to be devastating: Study

Scientists are getting closer to understanding the rare clotting disorder that has been linked to Covid-19 vaccines. A new report in the New England Journal of Medicine says that though clotting after receiving a Covid-19 shot is rare, it has the potential to be devastating.

The UK Researchers had found that 73% of people with very low platelet count had died.

Also, the vaccine developed by AstraZeneca and the University of Oxford (Covishield in India) was reported to have led to a blood-clotting syndrome in one in 50,000 people. All victims were under the age of 50. About 25% of the people who definitely or probably had the condition died, reported Bloomberg.

Sue Pavord, a researcher at Oxford University Hospitals said that the findings of the analysis done in the UK are "hugely important" to other countries. If they can recognize this condition and manage it promptly, they can continue with vaccination," said Pavord.

Experts said that the cases of the clotting disorder called immune thrombocytopenia and thrombosis have declined since age restrictions were introduced in the vaccination drive. The second shot does not raise the risk of the clotting disorder.

Scientists are hoping that new findings will help nations using AstraZeneca's vaccine to respond to the condition and decide who should receive the vaccine.